Grace Expands Michigan Fine Chemicals Site

W. R. Grace is expanding its fine chemicals contract development and manufacturing facility in South Haven, Michigan, USA. The project is scheduled for completion in January 2024.

The expansion will add a 4,000-gallon multi-use reactor train consisting of both glass-lined and stainless steel vessels, as well as a Hastelloy centrifuge to facilitate product isolation, which Grace said will greatly enhance the site’s commercial capabilities.

Once completed, the South Haven site will house three 4,000-gallon multi-use reactor trains to support the continued growth of small molecule drug production, including both custom and generic APIs, and cGMP intermediates.

“The additional capacity created through this project will enable our customers to develop critical drug therapies in areas such as oncology, diabetes, cardiovascular, and antivirals,” said Sandra Wisniewski, president, Grace Materials Technologies.

In June 2021, Grace acquired Albermarle’s fine chemical manufacturing services business as part of an expansion to support its pharmaceutical portfolio. The acquisition enabled Grace’s Materials Technologies division to triple its fine chemical footprint, while leveraging its existing chromatography resins and formulation excipients in the health and life sciences markets.

Author: Elaine Burridge, Freelance Journalist

© REB Images/Getty Images
© REB Images/Getty Images

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.